Search

everythinglearnresearchcommunity

for

Search:↓

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

PRF is preferred for better healing in dental surgeries.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.